2
Views
5
CrossRef citations to date
0
Altmetric
Original Article

The Cd5+ B Cells and Myasthenia Gravis

, , , , &
Pages 129-134 | Received 29 Nov 1994, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

A. Afeltra, G. M. Ferri, A. Amoroso, O. Leri, C. Pellegrino, F. Guldo, P. Garzia & A. Paggi. (1997) CD5 B Cells in autoimmune and non immune-mediated thyroid dysfunctions.. Endocrine Research 23:1-2, pages 81-94.
Read now

Articles from other publishers (4)

JunMei Zhang, Ge Jia, Qun Liu, Jue Hu, Mei Yan, BaiFeng Yang, Huan Yang, WenBin Zhou & Jing Li. (2015) Silencing miR-146a influences B cells and ameliorates experimental autoimmune myasthenia gravis. Immunology 144:1, pages 56-67.
Crossref
Sonia Berrih-Aknin, Samia Ragheb, Rozen Le Panse & Robert P. Lisak. (2013) Ectopic germinal centers, BAFF and anti-B-cell therapy in myasthenia gravis. Autoimmunity Reviews 12:9, pages 885-893.
Crossref
Sébastien Lacroix-Desmazes, Srini V Kaveri, Luc Mouthon, Ahidjo Ayouba, Evelyne Malanchère, Antonio Coutinho & Michel D Kazatchkine. (1998) Self-reactive antibodies (natural autoantibodies) in healthy individuals. Journal of Immunological Methods 216:1-2, pages 117-137.
Crossref
Tak W. Mak & John J. L. Simard. 1998. Handbook of Imune Response Genes. Handbook of Imune Response Genes 67 107 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.